|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 401/06 | (2006.01) |
| A61K 31/496 | (2006.01) | ||
| A61P 15/06 | (2006.01) |
| (11) | Number of the document | 1758886 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05755563.3 |
| Date of filing the European patent application | 2005-06-21 | |
| (97) | Date of publication of the European application | 2007-03-07 |
| (45) | Date of publication and mention of the grant of the patent | 2015-03-04 |
| (46) | Date of publication of the claims translation | 2015-06-25 |
| (86) | Number | PCT/EP2005/006760 |
| Date | 2005-06-21 |
| (87) | Number | WO 2006/000399 |
| Date | 2006-01-05 |
| (30) | Number | Date | Country code |
| 0414093 | 2004-06-23 | GB |
| (72) |
BORTHWICK, Alan, David, GlaxoSmithKline, GB
HICKEY, Deirdre, Mary, Bernadette, GlaxoSmithKline, GB
LIDDLE, John, GlaxoSmithKline, GB
MASON, Andrew, McMurtrie, GlaxoSmithKline, GB
|
| (73) |
Glaxo Group Limited,
980 Great West Road, Brentford, Middlesex TW8 9GS,
GB
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Piperazindionai kaip oksitocino receptoriaus antagonistai |
| PIPERAZINEDIONES AS OXYTOCIN RECEPTOR ANTAGONISTS |
| Payment date | Validity (years) | Amount | |
| 2017-05-24 | 13 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2018-06-21 |